Accepted for Publication: October 5, 2020.
Published Online: October 26, 2020. doi:10.1001/jamacardio.2020.5890
Corresponding Author: Aaron L. Baggish, MD, Cardiovascular Performance Program, Massachusetts General Hospital, 55 Fruit St, Yawkey Ste 5B, Boston, MA 02114 (abaggish@partners.org).
Author Contributions: Drs Baggish and Kim had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: All authors.
Acquisition, analysis, or interpretation of data: Kim, Thompson.
Drafting of the manuscript: Kim, Phelan, Martinez.
Critical revision of the manuscript for important intellectual content: Kim, Levine, Emery, Martinez, Chung, Thompson, Baggish.
Administrative, technical, or material support: Kim, Emery.
Supervision: Kim, Levine, Emery, Chung, Baggish.
Conflict of Interest Disclosures: Dr Kim reported receiving research funding for the study of athletes in competitive sports from the National Institute of Health/National Heart, Lung, and Blood Institute, compensation for his role as team cardiologist from the Atlanta Falcons (in the National Football League), and research stipends from the Atlanta Track Club. Dr Levine reported receiving compensation for his role as a consultant cardiologist for USA Track and Field and the US Olympic Committee. Dr Thompson reported receiving research funding to his institution from Sanofi, Regeneron, Esperion, Amarin, and Amgen; receiving consultation fees or speaker honoraria from Amgen, Amarin, Kowa, Regeneron, Sanofi, Esperion, Kowa, and Boehringer Ingelheim; and owning stock in AbbVie, Abbott Labs, CVS, General Electric, J&J, Medtronic, Sarepta, Boston Scientific, Myokardia, and Moderna. Dr Martinez reported receiving compensation for his role as league cardiology consultant for Major League Soccer outside the submitted work. Dr Baggish reported receiving research funding for the study of athletes in competitive sports from the National Institute of Health/National Heart, Lung, and Blood Institute, the National Football Players Association, and the American Heart Association and compensation for his role as team cardiologist from the US Olympic Committee/US Olympic Training Centers, US Soccer, US Rowing, the New England Patriots, the Boston Bruins, the New England Revolution, and Harvard University. No other disclosures were reported.
5.Bhatia
RT , Marwaha
S , Malhotra
A ,
et al. Exercise in the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) era: a question and answer session with the experts endorsed by the Section of Sports Cardiology & Exercise of the European Association of Preventive Cardiology (EAPC).
Eur J Prev Cardiol. 2020;27(12):1242-1251. doi:
10.1177/2047487320930596
PubMedGoogle ScholarCrossref 8.Puntmann
VO , Carerj
ML , Wieters
I ,
et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19).
JAMA Cardiol. Published July 27, 2020. doi:
10.1001/jamacardio.2020.3557
PubMedGoogle Scholar 10.Baggish
AL , Battle
RW , Beckerman
JG ,
et al; ACC’s Sports and Exercise Council Leadership Group. Sports cardiology: core curriculum for providing cardiovascular care to competitive athletes and highly active people.
J Am Coll Cardiol. 2017;70(15):1902-1918. doi:
10.1016/j.jacc.2017.08.055
PubMedGoogle ScholarCrossref 18.Baggish
AL , Battle
RW , Beaver
TA ,
et al. Recommendations on the use of multimodality cardiovascular imaging in young adult competitive athletes: a report from the American Society of Echocardiography in collaboration with the Society of Cardiovascular Computed Tomography and the Society for Cardiovascular Magnetic Resonance.
J Am Soc Echocardiogr. 2020;33(5):523-549. doi:
10.1016/j.echo.2020.02.009
PubMedGoogle ScholarCrossref 26.Collinson
P , Hammerer-Lercher
A , Suvisaari
J ,
et al; Working Group for Cardiac Markers, European Federation of Clinical Chemistry and Laboratory Medicine. How well do laboratories adhere to recommended clinical guidelines for the management of myocardial infarction: the Cardiac Marker Guidelines Uptake in Europe Study (CARMAGUE).
Clin Chem. 2016;62(9):1264-1271. doi:
10.1373/clinchem.2016.259515
PubMedGoogle ScholarCrossref 28.Maron
BJ , Udelson
JE , Bonow
RO ,
et al; American Heart Association Electrocardiography and Arrhythmias Committee of Council on Clinical Cardiology, Council on Cardiovascular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and American College of Cardiology. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3, hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology.
Circulation. 2015;132(22):e273-e280.
PubMedGoogle Scholar 31.Kiel
RJ , Smith
FE , Chason
J , Khatib
R , Reyes
MP . Coxsackievirus B3 myocarditis in C3H/HeJ mice: description of an inbred model and the effect of exercise on virulence.
Eur J Epidemiol. 1989;5(3):348-350. doi:
10.1007/BF00144836
PubMedGoogle ScholarCrossref 34.Caforio
AL , Pankuweit
S , Arbustini
E ,
et al; European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.
Eur Heart J. 2013;34(33):2636-2648, 2648a-2648d. doi:
10.1093/eurheartj/eht210PubMedGoogle ScholarCrossref 35.Pelliccia
A , Solberg
EE , Papadakis
M ,
et al. Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC).
Eur Heart J. 2019;40(1):19-33. doi:
10.1093/eurheartj/ehy730
PubMedGoogle ScholarCrossref 39.Yonker
LM , Neilan
AM , Bartsch
Y ,
et al. Pediatric SARS-CoV-2: clinical presentation, infectivity, and immune responses.
J Pediatr. 2020;S0022-3476(20)31023-4.
PubMedGoogle Scholar 40.Feldstein
LR , Rose
EB , Horwitz
SM ,
et al; Overcoming COVID-19 Investigators; CDC COVID-19 Response Team. Multisystem inflammatory syndrome in U.S. children and adolescents.
N Engl J Med. 2020;383(4):334-346. doi:
10.1056/NEJMoa2021680
PubMedGoogle ScholarCrossref 44.Svedberg
N , Sundström
J , James
S , Hållmarker
U , Hambraeus
K , Andersen
K . Long-term incidence of atrial fibrillation and stroke among cross-country skiers.
Circulation. 2019;140(11):910-920.
PubMedGoogle Scholar